Accurate ADHD diagnosis and individualized treatment require an understanding of diverse symptom presentations, developmental stages, gender differences, and common psychiatric comorbidities. This masterclass will explore evidence-based diagnostic approaches and the pharmacology, clinical evidence, and practical distinctions among next-generation stimulant formulations, including prodrugs, evening-dosed extended-release options, and transdermal delivery systems. Faculty will discuss how age, comorbidities, adherence patterns, and dosing flexibility inform treatment selection across the lifespan. Through shared decision-making strategies, participants will learn to align treatment with each patient’s needs, preferences, and functional goals.
Supported by an educational grant from Collegium Pharmaceutical.
